Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MRNA

Moderna Inc

Dec 07 • 02:28PM ET

79.57

Dollar change -1.03
Percentage change -1.28	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-9.34	Insider Own	13.11%	Shs Outstand	385.00M	Perf Week	2.41%
Market Cap	30.34B	Forward P/E	-	EPS next Y	-6.54	Insider Trans	-1.22%	Shs Float	331.32M	Perf Month	8.02%
Income	-3466.00M	PEG	-	EPS next Q	-1.40	Inst Own	63.40%	Short Float / Ratio	6.76% / 5.48	Perf Quarter	-26.08%
Sales	9.07B	P/S	3.35	EPS this Y	-159.94%	Inst Trans	0.92%	Short Interest	22.38M	Perf Half Y	-36.31%
Book/sh	35.31	P/B	2.25	EPS next Y	45.74%	ROA	-15.23%	Target Price	132.11	Perf Year	-54.15%
Cash/sh	19.86	P/C	4.01	EPS next 5Y	-	ROE	-22.04%	52W Range	62.55 - 217.25	Perf YTD	-55.70%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-23.54%	52W High	-63.37%	Beta	1.62
Dividend %	-	Quick Ratio	2.35	Sales past 5Y	668.04%	Gross Margin	31.87%	52W Low	27.21%	ATR	3.67
Employees	3900	Current Ratio	2.46	Sales Q/Q	-44.75%	Oper. Margin	-29.96%	RSI (14)	51.02	Volatility	5.22% 4.01%
Optionable	Yes	Debt/Eq	0.11	EPS Q/Q	-476.35%	Profit Margin	-38.22%	Rel Volume	0.75	Prev Close	80.60
Shortable	Yes	LT Debt/Eq	0.09	Earnings	Nov 02 BMO	Payout	0.00%	Avg Volume	4.08M	Price	79.57
Recom	2.27	SMA20	4.11%	SMA50	-5.00%	SMA200	-31.63%	Volume	2,382,450	Change	-1.28%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60
Aug-04-23	Downgrade	TD Cowen	Outperform → Market Perform	$145 → $125
Aug-03-23	Downgrade	Deutsche Bank	Buy → Hold	$125
Jul-24-23	Initiated	William Blair	Mkt Perform	$136.28
Jul-14-23	Initiated	HSBC Securities	Reduce	$97
Jun-26-23	Upgrade	UBS	Neutral → Buy	$221 → $191
Apr-26-23	Initiated	Guggenheim	Neutral
Mar-13-23	Upgrade	TD Cowen	Market Perform → Outperform	$150 → $180
Mar-02-23	Initiated	RBC Capital Mkts	Outperform	$200
Feb-24-23	Downgrade	SVB Securities	Market Perform → Underperform	$111 → $93
Dec-19-22	Upgrade	Jefferies	Hold → Buy	$170 → $275
Dec-14-22	Downgrade	Chardan Capital Markets	Buy → Neutral	$186 → $191
Oct-21-22	Upgrade	SVB Leerink	Underperform → Mkt Perform	$174 → $101
Sep-08-22	Upgrade	Deutsche Bank	Hold → Buy	$165
Feb-01-22	Upgrade	Redburn	Sell → Neutral
Jan-26-22	Upgrade	Deutsche Bank	Sell → Hold	$175
Jan-21-22	Upgrade	BofA Securities	Underperform → Neutral	$135 → $180
Jan-21-22	Initiated	UBS	Neutral	$221

Show Previous Ratings

Today 07:00AM	Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event (ACCESSWIRE)
Dec-04-23 06:00AM	3 Dirt Cheap Stocks You'll Regret Not Buying Before the New Year (Motley Fool)
Nov-30-23 08:50AM	Moderna Stock Looks Sick; Here's How To Take Advantage With Options (Investor's Business Daily)
07:00AM	Nobody wants to speak about COVID: Less than 3% of eligible Americans got a booster shot in September does that mean trouble for these 3 big vaccine stocks? (Moneywise)
Nov-29-23 10:01AM	Airbnb downgraded, Moderna initiated: Wall Street's top analyst calls (The Fly)
01:34PM	Loading…
Nov-28-23 01:34PM	AWS expands big pharma partnerships on manufacturing, AI, and R&D (Yahoo Finance)
01:34PM	AWS expands big pharma partnerships in manufacturing, AI, and R&D (Yahoo Finance)
09:00AM	YieldMax Launches Option Income Strategy ETF on C3.ai (ETF Database)
Nov-27-23 10:50PM	Moderna begins work on China mRNA manufacturing site (Reuters)
07:01PM	Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders (PR Newswire)
11:03AM	Is Moderna Stock A Sell After Its Sales Guidance Undercuts 2024 Expectations? (Investor's Business Daily)
09:50AM	11 Best Upside Stocks To Buy Right Now (Insider Monkey)
Nov-22-23 05:30AM	3 Biotech Stocks That Could Be Millionaire Makers (Motley Fool)
Nov-21-23 03:20PM	A Golden Age of Vaccines Is Here. What It Means for You. (Barrons.com)
09:04AM	CORRECTED-UPDATE 1-European Patent Office declares Moderna mRNA patent invalid (Reuters)
06:00AM	Loading…
06:00AM	Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics (PR Newswire)
05:37AM	BioNTech says European Patent Office has declared Moderna patent invalid (Reuters)
Nov-20-23 03:11PM	Dont Let the Q3 Earnings Miss Keep You From These 3 Stocks! (InvestorPlace)
Nov-14-23 07:00AM	Moderna to Host Second Environmental, Social and Governance (ESG) Investor Event on December 7th, 2023 (ACCESSWIRE) +5.54%
Nov-13-23 05:00AM	3 Cathie Wood Bargain Buys That Should Be on Your List Too (Motley Fool)
Nov-11-23 05:30AM	Where Will Novavax Be in 3 Years? (Motley Fool)
Nov-10-23 10:15AM	2 Top Biotech Stocks to Buy Right Now (Motley Fool)
06:29AM	Why Moderna Stock Was Cratering This Week (Motley Fool)
Nov-09-23 08:45AM	Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy. (Motley Fool)
03:49AM	Top 20 Drug Companies in the US by Revenue (Insider Monkey)
Nov-08-23 04:15PM	Moderna to Present at Upcoming Conferences in November 2023 (ACCESSWIRE)
07:00AM	Moderna Highlights its Digital and AI Strategy and Progress at Second Digital Investor Event (ACCESSWIRE)
Nov-07-23 08:00AM	Moderna Tops BioSpaces Best Places to Work Ranking for Third Consecutive Year (ACCESSWIRE)
05:09AM	Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year? (Motley Fool)
05:00AM	Cathie Wood Just Bought This Struggling Stock After Its Billion-Dollar Quarterly Loss. Should You? (Motley Fool)
04:21PM	Loading…
Nov-06-23 04:21PM	Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday (Investor's Business Daily) -7.04%
Nov-05-23 06:18AM	Down 84% From Its Peak. Is It Finally Time to Buy Moderna? (Motley Fool)
Nov-04-23 01:18PM	Moderna, Inc. (NASDAQ:MRNA) Q3 2023 Earnings Call Transcript (Insider Monkey)
05:00AM	Moderna May Be Facing Its Toughest Moment Ever. Time to Sell? (Motley Fool)
01:09AM	The Moderna Inc (MRNA) Company: A Short SWOT Analysis (GuruFocus.com)
Nov-03-23 06:30PM	Moderna (MRNA) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +8.84%
08:20AM	Moderna adjusts to changing outlook for COVID vaccine demand (BioPharma Dive)
07:09AM	Modernas CFO on the $25 billion innovation plan to work past the post-COVID slump (Fortune)
02:10AM	Uber notches upgrade ahead of Q3 earnings: 4 big analyst picks (Investing.com)
Nov-02-23 08:43PM	Analyst Report: Moderna, Inc. (Morningstar Research) -6.52%
07:26PM	Why Moderna Stock Plummeted by Almost 7% Today (Motley Fool)
06:00PM	Moderna Takes $1.3 Billion Hit From Sluggish Covid Vaccine Uptake (Motley Fool)
05:11PM	S&P 500 Gains and Losses Today: Starbucks Shares Jump Following Profit Record (Investopedia)
04:32PM	Moderna Shares Slide After Posting a Loss on Falling COVID-19 Vaccine Sales and Production (Investopedia)
04:25PM	Moderna will break even in 2026: CEO Stéphane Bancel (Yahoo Finance)
04:03PM	Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat (Investor's Business Daily)
02:18PM	Moderna Stock Falls After Big Covid Vaccine Writedown (The Wall Street Journal)
01:28PM	How Moderna aims to break even by 2026 (Yahoo Finance Video)
01:20PM	Markets Jump at Midday Amid Optimism the Fed Could Be Done Raising Interest Rates in 2023 (Investopedia)
01:00PM	Moderna (MRNA) Q3 2023 Earnings Call Transcript (Motley Fool)
12:19PM	Moderna (MRNA) Beats on Q3 Earnings & Sales, Expects Lower COVID Demand (Zacks)
10:43AM	Moderna Stock Slips After Big Covid Vaccine Writedown (The Wall Street Journal)
10:34AM	Bancel suggests Moderna could be open to out-licensing if sales struggle (FierceBiotech.com)
09:50AM	Midday movers: Starbucks, Moderna, Eli Lilly and more (Investing.com)
09:25AM	Moderna CEO Stephane Bancel on Q3 results (CNBC TV)
09:04AM	Moderna: Q3 Earnings Snapshot (Associated Press Finance)
08:25AM	Moderna posts quarterly loss as company takes $1.3 billion write-down on unused Covid shots (CNBC TV)
08:01AM	Moderna Inc (MRNA) Reports Q3 2023 Financial Results (GuruFocus.com)
07:17AM	Moderna in earnings miss as demand for Covid shots falls (Financial Times)
06:48AM	UPDATE 1-Moderna tempers 2023 COVID vaccine sales forecast (Reuters)
06:34AM	Moderna reins in 2023 COVID vaccine forecast, shares tumble (Reuters)
06:30AM	Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares (Investor's Business Daily)
06:30AM	Moderna revenue tops expectations, expects to return to sales growth in 2025 (Reuters)
06:30AM	Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates (ACCESSWIRE)
06:30AM	Moderna Reports Big Quarterly Loss in Post-Pandemic Reset (Barrons.com)
Nov-01-23 10:30AM	Flagship Pioneering Launches Pioneering Intelligence (PR Newswire)
10:13AM	Exploring Analyst Estimates for Moderna (MRNA) Q3 Earnings, Beyond Revenue and EPS (Zacks)
06:09AM	UPDATE 1-Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say (Reuters)
06:03AM	Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say (Reuters)
Oct-31-23 12:35PM	Never Mind Covid, Investors Want a Pfizer Obesity Pill (The Wall Street Journal)
10:01AM	Gilead Sciences (GILD) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-30-23 09:22AM	Moderna joins CEPI's 100 Days Mission to advance pandemic preparedness (FierceBiotech.com)
05:25AM	11 Best Immunotherapy Stocks To Buy Now (Insider Monkey)
03:00AM	CEPI and Moderna Harness mRNA Technology to Advance 100 Days Mission (ACCESSWIRE)
Oct-29-23 10:34AM	15 Countries with the Highest Number of Heart Diseases (Insider Monkey)
Oct-27-23 05:24PM	What an updated COVID vaccine will mean for Moderna (Yahoo Finance Video) -5.36%
05:17PM	Moderna stock decline: What it will take to get it moving higher again (Yahoo Finance Video)
05:00AM	Got $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now (Motley Fool)
Oct-26-23 02:50PM	Moderna Named a Top Employer by Science for Ninth Consecutive Year (ACCESSWIRE)
10:38AM	Pfizer Gets Good Results From Covid-Flu Shot. The Race Is on With Moderna. (Barrons.com)
10:02AM	Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline (Zacks)
08:44AM	Pfizer, BioNTech prep flu-COVID mRNA combo shot for phase 3, reprising Moderna race after seeing early data (FierceBiotech.com)
08:26AM	Pfizer Progresses Combo Covid Vaccine. Its Competing With Moderna. (Barrons.com)
Oct-25-23 12:34PM	Is Moderna Stock A Buy After Reiterating Its Guidance Following Pfizer's $9 Billion Cut? (Investor's Business Daily)
09:10AM	Moderna (MRNA) to Report Q3 Earnings: What's in the Cards? (Zacks)
06:54AM	Caris, Moderna partner for mRNA-based oncology therapeutics advancement (Pharmaceutical Business Review)
Oct-24-23 05:50PM	Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know (Zacks)
08:48AM	Moderna Stock Hasn't Been This Cheap Since 2020: Is Now the Time to Buy? (Motley Fool)
07:00AM	Moderna Announces First Participant Dosed in Phase 3 Study of mRNA-1083, a Combination Vaccine Against Influenza and COVID-19 (ACCESSWIRE)
06:30AM	Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology Therapeutics (PR Newswire)
05:30AM	The Best Stocks to Invest $5,000 In Right Now (Motley Fool)
Oct-23-23 05:30AM	3 No-Brainer Stocks to Buy Right Now for Less than $100 (Motley Fool)
Oct-22-23 10:13AM	Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks This Year? (Motley Fool)
Oct-20-23 04:33PM	Moderna Shaves Off $7 Billion in Value After Pfizer Warning (Bloomberg)
Oct-19-23 05:14PM	Why Moderna Stock Is Sinking This Week (Motley Fool)
10:30AM	Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines (PR Newswire)
07:40AM	Moderna to Host Second Digital Investor Event on November 8th, 2023 (ACCESSWIRE)
05:00AM	Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point (Motley Fool)
03:28AM	Japan agreed to buy additional COVID-19 vaccine doses from Pfizer and Moderna (Reuters)
Oct-18-23 05:50PM	Moderna (MRNA) Stock Moves -0.37%: What You Should Know (Zacks)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoge Stephen	President	Dec 04	Sale	79.31	309	24,508	1,576,063	Dec 05 04:07 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 04	Sale	79.31	111	8,804	7,336	Dec 05 04:10 PM
Hoge Stephen	President	Nov 29	Sale	79.81	1,136	90,666	1,575,721	Nov 30 04:11 PM
Hoge Stephen	President	Nov 10	Sale	68.76	263	18,084	1,574,446	Nov 13 04:02 PM
AFEYAN NOUBAR	Director	Nov 01	Sale	76.00	10,000	760,032	2,146,931	Nov 03 07:00 PM
AFEYAN NOUBAR	Director	Oct 25	Sale	76.99	10,000	769,854	2,156,931	Oct 27 07:00 PM
AFEYAN NOUBAR	Director	Oct 11	Sale	103.30	15,000	1,549,441	2,166,931	Oct 13 07:00 PM
Mock James M	Chief Financial Officer	Oct 06	Sale	102.50	2,858	292,953	2,952	Oct 10 04:51 PM
AFEYAN NOUBAR	Director	Oct 04	Sale	102.72	15,000	1,540,845	2,181,931	Oct 06 07:02 PM
AFEYAN NOUBAR	Director	Sep 27	Sale	98.96	10,000	989,646	2,196,931	Sep 29 07:00 PM
AFEYAN NOUBAR	Director	Sep 20	Sale	104.74	15,000	1,571,090	2,206,931	Sep 22 07:00 PM
Hoge Stephen	President	Sep 15	Sale	112.99	15,000	1,694,850	1,574,187	Sep 18 04:06 PM
AFEYAN NOUBAR	Director	Sep 13	Sale	109.70	15,000	1,645,522	2,221,931	Sep 15 07:00 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 08	Sale	107.22	557	59,722	7,215	Sep 11 04:02 PM
AFEYAN NOUBAR	Director	Sep 06	Sale	107.61	15,000	1,614,094	1,982,209	Sep 08 07:01 PM
Garay Arpa	Chief Commercial Officer	Sep 06	Sale	108.40	574	62,219	3,113	Sep 07 04:46 PM
Hoge Stephen	President	Sep 05	Sale	111.44	320	35,660	1,589,187	Sep 06 04:08 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 05	Sale	111.44	115	12,815	6,634	Sep 06 04:17 PM
AFEYAN NOUBAR	Director	Aug 30	Sale	115.46	15,000	1,731,951	1,997,209	Sep 01 07:00 PM
Hoge Stephen	President	Aug 29	Sale	115.01	1,135	130,542	1,588,855	Aug 30 04:07 PM
AFEYAN NOUBAR	Director	Aug 23	Sale	115.51	15,000	1,732,613	2,012,209	Aug 25 07:00 PM
Hoge Stephen	President	Aug 17	Sale	100.00	15,000	1,500,000	1,587,579	Aug 18 05:16 PM
AFEYAN NOUBAR	Director	Aug 16	Sale	97.56	10,000	975,614	2,027,209	Aug 18 07:01 PM
Hoge Stephen	President	Aug 10	Sale	102.53	247	25,325	1,602,579	Aug 11 04:18 PM
AFEYAN NOUBAR	Director	Aug 02	Sale	110.99	15,000	1,664,876	2,037,209	Aug 04 07:00 PM
AFEYAN NOUBAR	Director	Jul 26	Sale	120.42	15,000	1,806,229	2,052,209	Jul 28 07:05 PM
AFEYAN NOUBAR	Director	Jul 19	Sale	125.48	15,000	1,882,152	2,067,209	Jul 21 07:00 PM
Hoge Stephen	President	Jul 17	Sale	120.60	15,000	1,809,000	1,602,303	Jul 18 04:35 PM
AFEYAN NOUBAR	Director	Jul 12	Sale	125.81	15,000	1,887,081	2,082,209	Jul 14 07:01 PM
AFEYAN NOUBAR	Director	Jul 05	Sale	124.73	15,000	1,870,933	2,097,209	Jul 07 07:00 PM
Bancel Stephane	Chief Executive Officer	Jun 28	Option Exercise	0.99	27,155	26,883	5,439,101	Jun 30 04:51 PM
Bancel Stephane	Chief Executive Officer	Jun 28	Sale	121.63	27,155	3,302,907	5,411,946	Jun 30 04:51 PM
AFEYAN NOUBAR	Director	Jun 28	Sale	121.54	15,000	1,823,160	2,112,209	Jun 30 07:02 PM
Bancel Stephane	Chief Executive Officer	Jun 22	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 23 04:03 PM
Bancel Stephane	Chief Executive Officer	Jun 22	Sale	119.41	40,000	4,776,427	5,411,946	Jun 23 04:03 PM
Bancel Stephane	Chief Executive Officer	Jun 21	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 23 04:03 PM
Bancel Stephane	Chief Executive Officer	Jun 21	Sale	121.98	40,000	4,879,287	5,411,946	Jun 23 04:03 PM
AFEYAN NOUBAR	Director	Jun 21	Sale	121.95	15,000	1,829,227	2,127,209	Jun 23 07:01 PM
Bancel Stephane	Chief Executive Officer	Jun 15	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 16 04:15 PM
Bancel Stephane	Chief Executive Officer	Jun 15	Sale	128.41	40,000	5,136,388	5,411,946	Jun 16 04:15 PM
Hoge Stephen	President	Jun 15	Sale	125.93	15,000	1,888,950	1,617,303	Jun 16 04:10 PM
Bancel Stephane	Chief Executive Officer	Jun 14	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 16 04:15 PM
Bancel Stephane	Chief Executive Officer	Jun 14	Sale	126.14	40,000	5,045,486	5,411,946	Jun 16 04:15 PM
AFEYAN NOUBAR	Director	Jun 14	Sale	126.18	15,000	1,892,627	2,142,209	Jun 16 07:00 PM
Bancel Stephane	Chief Executive Officer	Jun 08	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 09 04:14 PM
Bancel Stephane	Chief Executive Officer	Jun 08	Sale	124.01	40,000	4,960,364	5,411,946	Jun 09 04:14 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 08	Sale	124.09	565	70,111	6,516	Jun 09 04:09 PM
Bancel Stephane	Chief Executive Officer	Jun 07	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 09 04:14 PM
Bancel Stephane	Chief Executive Officer	Jun 07	Sale	125.81	40,000	5,032,420	5,411,946	Jun 09 04:14 PM
AFEYAN NOUBAR	Director	Jun 07	Sale	125.91	15,000	1,888,601	2,157,209	Jun 09 07:00 PM
Garay Arpa	Chief Commercial Officer	Jun 06	Sale	125.75	2,290	287,972	2,547	Jun 07 04:05 PM
Hoge Stephen	President	Jun 02	Sale	130.32	309	40,270	1,632,303	Jun 05 04:16 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 02	Sale	130.32	110	14,336	5,942	Jun 05 04:20 PM
Bancel Stephane	Chief Executive Officer	Jun 01	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 02 04:46 PM
Bancel Stephane	Chief Executive Officer	Jun 01	Sale	127.96	40,000	5,118,473	5,411,946	Jun 02 04:46 PM
Bancel Stephane	Chief Executive Officer	May 31	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 02 04:46 PM
Bancel Stephane	Chief Executive Officer	May 31	Sale	126.91	40,000	5,076,558	5,411,946	Jun 02 04:46 PM
AFEYAN NOUBAR	Director	May 31	Sale	127.35	15,000	1,910,322	2,172,209	Jun 02 07:00 PM
Hoge Stephen	President	May 30	Sale	124.95	1,181	147,569	1,631,961	May 31 04:21 PM
Bancel Stephane	Chief Executive Officer	May 25	Option Exercise	0.99	40,000	39,600	5,451,946	May 26 04:59 PM
Bancel Stephane	Chief Executive Officer	May 25	Sale	127.36	40,000	5,094,421	5,411,946	May 26 04:59 PM
Bancel Stephane	Chief Executive Officer	May 24	Option Exercise	0.99	40,000	39,600	5,451,946	May 26 04:59 PM
Bancel Stephane	Chief Executive Officer	May 24	Sale	131.43	40,000	5,257,212	5,411,946	May 26 04:59 PM
Bancel Stephane	Chief Executive Officer	May 18	Option Exercise	0.99	40,000	39,600	5,451,946	May 19 04:12 PM
Bancel Stephane	Chief Executive Officer	May 18	Sale	123.77	40,000	4,950,999	5,411,946	May 19 04:12 PM
Bancel Stephane	Chief Executive Officer	May 17	Option Exercise	0.99	40,000	39,600	5,451,946	May 19 04:12 PM
Bancel Stephane	Chief Executive Officer	May 17	Sale	125.32	40,000	5,012,648	5,411,946	May 19 04:12 PM
Bancel Stephane	Chief Executive Officer	May 11	Option Exercise	0.99	40,000	39,600	5,451,946	May 12 04:08 PM
Bancel Stephane	Chief Executive Officer	May 11	Sale	127.26	40,000	5,090,486	5,411,946	May 12 04:08 PM
Bancel Stephane	Chief Executive Officer	May 10	Option Exercise	0.99	40,000	39,600	5,451,946	May 12 04:08 PM
Bancel Stephane	Chief Executive Officer	May 10	Sale	131.60	40,000	5,264,032	5,411,946	May 12 04:08 PM
Hoge Stephen	President	May 10	Sale	133.37	250	33,344	1,630,732	May 11 04:09 PM
Bancel Stephane	Chief Executive Officer	May 04	Option Exercise	0.99	40,000	39,600	5,451,946	May 05 04:08 PM
Bancel Stephane	Chief Executive Officer	May 04	Sale	135.70	40,000	5,428,125	5,411,946	May 05 04:08 PM
Bancel Stephane	Chief Executive Officer	May 03	Option Exercise	0.99	40,000	39,600	5,451,946	May 05 04:08 PM
Bancel Stephane	Chief Executive Officer	May 03	Sale	131.29	40,000	5,251,498	5,411,946	May 05 04:08 PM
Bancel Stephane	Chief Executive Officer	Apr 27	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 28 04:51 PM
Bancel Stephane	Chief Executive Officer	Apr 27	Sale	130.61	40,000	5,224,570	5,411,946	Apr 28 04:51 PM
Bancel Stephane	Chief Executive Officer	Apr 26	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 28 04:51 PM
Bancel Stephane	Chief Executive Officer	Apr 26	Sale	131.73	40,000	5,269,140	5,411,946	Apr 28 04:51 PM
Bancel Stephane	Chief Executive Officer	Apr 20	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 21 05:05 PM
Bancel Stephane	Chief Executive Officer	Apr 20	Sale	142.99	40,000	5,719,540	5,411,946	Apr 21 05:05 PM
Bancel Stephane	Chief Executive Officer	Apr 19	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 21 05:05 PM
Bancel Stephane	Chief Executive Officer	Apr 19	Sale	142.88	40,000	5,715,262	5,411,946	Apr 21 05:05 PM
Bancel Stephane	Chief Executive Officer	Apr 13	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 14 04:02 PM
Bancel Stephane	Chief Executive Officer	Apr 13	Sale	160.76	40,000	6,430,340	5,411,946	Apr 14 04:02 PM
Bancel Stephane	Chief Executive Officer	Apr 12	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 14 04:02 PM
Bancel Stephane	Chief Executive Officer	Apr 12	Sale	156.68	40,000	6,267,335	5,411,946	Apr 14 04:02 PM
Bancel Stephane	Chief Executive Officer	Apr 06	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 07 05:31 PM
Bancel Stephane	Chief Executive Officer	Apr 06	Sale	157.47	40,000	6,298,950	5,411,946	Apr 07 05:31 PM
Bancel Stephane	Chief Executive Officer	Apr 05	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 07 05:31 PM
Bancel Stephane	Chief Executive Officer	Apr 05	Sale	154.64	40,000	6,185,585	5,411,946	Apr 07 05:31 PM
Bancel Stephane	Chief Executive Officer	Mar 30	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 31 04:10 PM
Bancel Stephane	Chief Executive Officer	Mar 30	Sale	148.63	40,000	5,945,054	5,411,946	Mar 31 04:10 PM
Bancel Stephane	Chief Executive Officer	Mar 29	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 31 04:10 PM
Bancel Stephane	Chief Executive Officer	Mar 29	Sale	148.35	40,000	5,934,076	5,411,946	Mar 31 04:10 PM
Bancel Stephane	Chief Executive Officer	Mar 23	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 24 04:11 PM
Bancel Stephane	Chief Executive Officer	Mar 23	Sale	149.19	40,000	5,967,683	5,411,946	Mar 24 04:11 PM
Bancel Stephane	Chief Executive Officer	Mar 22	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 24 04:11 PM
Bancel Stephane	Chief Executive Officer	Mar 22	Sale	150.25	40,000	6,009,804	5,411,946	Mar 24 04:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your FINVIZ experience